PRPH - ProPhase Labs, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
2.36
+0.04 (+1.72%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close2.32
Open2.35
Bid2.15 x 300
Ask2.40 x 3000
Day's Range2.33 - 2.40
52 Week Range1.78 - 2.53
Volume11,784
Avg. Volume6,167
Market Cap29.331M
Beta0.80
PE Ratio (TTM)0.98
EPS (TTM)2.40
Earnings DateMar 27, 2017 - Mar 31, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.55
Trade prices are not sourced from all markets
  • American City Business Journals2 months ago

    ProPhase completes $4.5M tender offer

    ProPhase Labs Inc. is buying back $4.5 million of its common stock, completing a tender offer announced earlier this month. The Doylestown, Pa., natural health products company said Thursday it has accepted for purchase about 1.95 million shares at $2.30 per share. ProPhase is the original developer of Cold-Eeze zinc lozenges for cold suffers.

  • GlobeNewswire2 months ago

    ProPhase Labs, Inc. Announces Final Results of Its Tender Offer

    DOYLESTOWN, Pa., Dec. 21, 2017-- ProPhase Labs, Inc., a diversified natural health medical science company, announced today the final results of its tender offer to purchase up to 1,700,000 shares of its ...

  • GlobeNewswire2 months ago

    ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer

    DOYLESTOWN, Pa., Dec. 19, 2017-- ProPhase Labs, Inc., a diversified natural health medical science company, announced today the preliminary results of its tender offer to purchase up to 1,700,000 shares ...

  • Can ProPhase Labs Inc (PRPH) Continue To Outperform Its Industry?
    Simply Wall St.3 months ago

    Can ProPhase Labs Inc (PRPH) Continue To Outperform Its Industry?

    ProPhase Labs Inc (NASDAQ:PRPH) delivered an ROE of 70.52% over the past 12 months, which is an impressive feat relative to its industry average of 16.15% during the same period.Read More...

  • ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 24, 2017
    Capital Cube3 months ago

    ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 24, 2017

    Categories: Yahoo FinanceGet free summary analysis ProPhase Labs, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of ProPhase Labs, Inc. – Mannatech, Incorporated, Reliv’ International, Inc., USANA Health Sciences, Inc., Nature’s Sunshine Products, Inc., Cyanotech Corporation, XOMA Corporation and True Drinks Holdings, Inc. (MTEX-US, RELV-US, ... Read more (Read more...)

  • GlobeNewswire3 months ago

    ProPhase Labs, Inc. Announces Commencement of Tender Offer to Repurchase Up to 1.7 Million Shares of Its Common Stock at Price of $2.30 Per Share

    DOYLESTOWN, Pa., Nov. 20, 2017-- ProPhase Labs, Inc., a diversified natural health medical science company, today announced that it has commenced a tender offer to purchase up to 1.7 million shares of ...

  • Is ProPhase Labs Inc (PRPH) A Buy At Its Current Price?
    Simply Wall St.5 months ago

    Is ProPhase Labs Inc (PRPH) A Buy At Its Current Price?

    ProPhase Labs Inc (NASDAQ:PRPH) is trading with a trailing P/E of 2.4x, which is lower than the industry average of 24.1x. While this makes PRPH appear like a great stockRead More...

  • ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017
    Capital Cube6 months ago

    ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017

    Categories: Yahoo FinanceGet free summary analysis ProPhase Labs, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of ProPhase Labs, Inc. – Mannatech, Incorporated, Reliv’ International, Inc., USANA Health Sciences, Inc., Nutraceutical International Corporation, Nature’s Sunshine Products, Inc., Oragenics, Inc., Cyanotech Corporation and XOMA Corporation (MTEX-US, ... Read more (Read more...)

  • Marketwired8 months ago

    ProPhase Labs Repurchases 1,061,980 Shares of Its Common Stock

    ProPhase Labs, Inc. today reported that that on June 12, 2017 it entered into a Stock Purchase Agreement with each of Mark S. Leventhal, a former director of the Company, and certain other persons and ...

  • ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q1, 2017 By the Numbers : May 17, 2017
    Capital Cube9 months ago

    ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q1, 2017 By the Numbers : May 17, 2017

    Categories: Yahoo FinanceGet free summary analysis ProPhase Labs, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of ProPhase Labs, Inc. – Mannatech, Incorporated, Reliv’ International, Inc., USANA Health Sciences, Inc., Nutraceutical International Corporation, Nature’s Sunshine Products, Inc., XOMA Corporation and Emisphere Technologies, Inc. (MTEX-US, RELV-US, ... Read more (Read more...)

  • Marketwired9 months ago

    ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2017

    ProPhase Labs, Inc. today reported its financial results for the three months ended March 31, 2017. As previously announced, effective March 29, 2017 and with the approval of the Company's stockholders, ...

  • Marketwired10 months ago

    ProPhase Provides Shareholder Update

    ProPhase Labs, Inc. , a diversified natural health medical science company , provides an update to shareholders today.As previously reported, on March 29, 2017, the Company completed its sale of...

  • Marketwired11 months ago

    ProPhase Labs, Inc. Completes Sale of Cold-EEZE(R) Business to Mylan

    ProPhase Labs, Inc. , a diversified natural health medical science company , announced today that it has completed the sale of its Cold-EEZE® business to a wholly-owned subsidiary of Mylan N.V....

  • ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 13, 2017
    Capital Cube11 months ago

    ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 13, 2017

    Categories: Yahoo Finance Get free summary analysis ProPhase Labs, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of ProPhase Labs, Inc. – USANA Health Sciences, Inc., Nature’s Sunshine Products, Inc., Nutraceutical International Corporation, Albany Molecular Research, Inc. and Cyanotech Corporation (USNA-US, NATR-US, NUTR-US, AMRI-US and CYAN-US) ... Read more (Read more...)

  • Marketwiredlast year

    ProPhase Labs Reports Financial Results for the Year Ended December 31, 2016

    ProPhase Labs, Inc. today reported its net sales were $21.0 million for the year ended December 31, 2016 as compared to net sales of $20.6 million for the year ended December 31, 2015. The Company incurred ...